Approximately 50% of all human cancers lost p53 function due to gene mutations, which occur primarily within the p53 DNA binding domain, underscoring the necessity of p53 binding to DNA for its tumor suppressor function (Vousden and Lane, 2007). This evidence concerns the gene TP53 and neoplasm.